Abstract
Bovine pulmonary artery smooth muscle possesses the tissue inhibitor of matrix metalloproteinase-2 (TIMP-2) as revealed by Western immunoblot study of its cytosol fraction with bovine polyclonal TIMP-2 antibody. This potent polypeptide inhibitor of matrix metalloproteinases (MMPs) was purified to homogeneity from cytosol fraction of bovine pulmonary artery smooth muscle. This inhibitor was purified by ammonium sulfate precipitation followed by gelatin sepharose and lentil lectin sepharose affinity chromatography and continuous elution electrophoresis by Prep Cell Model 491 (Bio-Rad, USA). SDS-PAGE revealed that the inhibitor has an apparent molecular mass of 21 kDa and was confirmed as TIMP-2 by (i) Western immunoblot assay using bovine polyclonal TIMP-2 antibody; and also by (ii) amino terminal amino acid sequence analysis of the purified inhibitor is found to be identical with TIMP-2 obtained from other sources. The purified 21 kDa inhibitor was found to be active against matrix metalloproteinase-2 (MMP-2, 72 kDa gelatinase) and matrix metalloproteinase-9 (MMP-9, 92 kDa gelatinase), the ambient MMPs in the pulmonary artery smooth muscle. The inhibitor was also found to be sensitive to the activated 72 kDa gelatinase-TIMP-2 complex and also active human interstitial collagenase. By contrast, it was found to be insensitive to the serine proteases: trypsin and plasmin. The inhibitor was heat and acid resistant and it had the sensitivity to trypsin degradation and reduction-alkylation. Treatment of the inhibitor with hydrogen peroxide, superoxide generating system (hypoxanthine plus xanthine oxidase) and peroxynitrite inactivated the inhibitor.
Similar content being viewed by others
References
Das S, Chakraborti T, Mandal M, Mandal A, Chakraborti S: Role of membrane-associated Ca2+ dependent matrix metalloprotease-2 in the oxidant activation of Ca2+ ATPase by tertiary butylhydroperoxide. Mol Cell Biochem 237: 85-93, 2002
Mandal M, Chakraborti T, Das S, Mandal A, Chakraborti S: Matrix metalloprotease-2 mediated activation of Ca2+ ATPase by superoxide radical (O2·−) in plasma membrane of bovine pulmonary vascular smooth muscle. Indian J Biochem Biophys 39:390-396, 2002
Chakraborti T, Das S, Mandal M, Mandal A, Chakraborti S: Role of Ca2+ dependent matrix metalloprotease-2 in stimulating Ca2+ ATPase activity under peroxynitrite treatment in pulmonary vascular smooth muscle plasma membrane. IUBMB Life 53: 167-173, 2002
Murphy G, Cawston TE, Galloway WA, Barnes MJ, Bunning RA, Mercer E, Reynolds JJ, Burgeson RE: Metalloproteinases from rabbit bone culture medium degrade types IV and V collagens, laminin and fibronectin. Biochem J 199: 807-811, 1981
Nagase H, Woessner JF Jr: Matrix metalloproteinases. J Biol Chem 274: 21491-21504, 1999
Giannelli G, Antonaci S: Gelatinases and their inhibitors in tumor metastasis: From biological research to medical applications. Histol Histopathol. 17: 339-345, 2002
Johansson N, Ahonen M, Kahari VM: Matrix metalloproteinases in tumor invasion. Cell Mol Life Sci 57: 5-15, 2000
Chang C, Werb Z: The many faces of metalloproteases: Cell growth, invasion, angiogenesis and metastasis. Trends Cell Biol 11: S37-S43, 2001
Corbel M, Boichot E, Lagente V: Role of gelatinases MMP-2 and MMP-9 in tissue remodeling following acute lung injury. Braz J Med Biol Res 33: 749-754, 2000
Ohbayashi H: Matrix metalloproteinases in lung diseases. Curr Prot Pep Sci 3: 409-421, 2002
Woessner JF Jr: Matrix metalloproteinases and their inhibitors in connective tissue remodeling. FASEB J 5: 2145-2154, 1991
Dayer JM, de Rochemonteix B, Burrus B, Demczuk S, Dinarello CA: Human recombinant interleukin 1 stimulates collagenase and prostaglandin E2 production by human synovial cells. J Clin Invest 77: 645-648, 1986
Wooley DE: In: R.E. Piez, A.H. Reddi (eds). Extracellular Matrix Biochemistry. Elsevier, New York, 1984, pp 119-159
Eisenstein R, Sorgente N, Soble LW, Miller A, Kuettner KE: The resistance of certain tissues to invasion: Penetrability of explanted tissues by vascularized mesenchyme. Am J Pathol 73: 765-774, 1973
Travis J, Salvesen GS: Human plasma proteinase inhibitors. Annu Rev Biochem 52: 655-709, 1983
Birkedal-Hansen H, Moore WGI, Bodden MK, Windsor LJ, Birkedal-Hansen B, DeCarlo A, Engler JA: Matrix metalloproteinases: A review. Crit Rev Oral Biol Med 4: 197-250, 1993
Woessner JF Jr: Matrix metalloproteinase inhibition. From the Jurassic to the third millennium. Ann NY Acad Sci USA 878: 388-403, 1999
De Clerck YA, Yean TD, Ratzkin BJ, Lu HS, Langley KE: Purification and characterization of two related but distinct metalloproteinase inhibitors secreted by bovine aortic endothelial cells. J Biol Chem 264: 17445-17453, 1989
Stetler-Stevenson WG, Krutzsch HC, Liotta LA: Tissue inhibitor of metalloproteinase (TIMP-2). A new member of the metalloproteinase inhibitor family. J Biol Chem 264: 17374-17378, 1989
Murphy G, Willenbrock F: Tissue inhibitors of matrix metalloendopeptidases. Meth Enzymol 248: 496-510, 1995
Kolkenbrock H, Orgel D, Hecker-Kia A, Niack W, Ulbrich N: The complex between a tissue inhibitor of metalloproteinases (TIMP-2) and 72-kDa progelatinase is a metalloproteinase inhibitor. Eur J Biochem 198: 775-781, 1991
Howard EW, Bullen EC, Banda MJ: Regulation of the autoactivation of human 72-kDa progelatinase by tissue inhibitor of metalloproteinases-2. J Biol Chem 266: 13064-13069, 1991
Roswit WT, McCourt DW, Partridge NC, Jeffrey JJ: Purification and sequence analysis of two rat tissue inhibitors of metalloproteinases. Arch Biochem Biophys 292: 402-410, 1992
Goldberg GI, Marmer BL, Grant GA, Eisen AZ, Wilhelm S, He CS: Human 72-kilodalton type IV collagenase forms a complex with a tissue inhibitor of metalloproteases designated TIMP-2. Proc Natl Acad Sci USA 86: 8207-8211, 1989
Kamp HH, Wirtz KW: Phosphatidylcholine exchange protein from beef liver. Meth Enzymol 32: 140-146, 1974
Towbin H, Staehelin T, Gordon J: Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: Procedure and some applications. Proc Natl Acad Sci 76: 4350-4354, 1979
Baer HP, Vriend RA. Cytosolic enzyme leakage from isolated smooth muscle preparations. Can J Physiol Pharmacol 63: 164-165, 1985
Bausback HH, Ward PE: Vascular, post proline cleaving enzyme: Metabolism of vasoactive peptides. Adv Exp Med Biol 198: 397-404, 1986
Tenu JP, Etore F, Le Doan T: A simple method for the study of cytosolic content of oligonucleotides in cells. CR Acad Sci III 320: 477-486, 1997
Reiss K, Meggs LG, Li P, Olivetti G, Capasso JM, Anversa P: Upregulation of IGF1, IGF1-receptor, and late growth related genes in ventricular myocytes acutely after infarction in rats. J Cell Physiol 158: 160-168, 1994
Juan G, Traganos F, Darzynkiewicz Z: Histone H3 phosphorylation in human monocytes and during HL-60 cell differentiation. Exp Cell Res 246: 212-20, 1999
Mookhtiar KA, Mallya SK, Van Wart HE: Properties of radiolabeled type I, II, and III collagens related to their use as substrates in collagenase assays. Anal Biochem 158: 322-33, 1986
Stetler-Stevenson WG, Krutzsch HC, Wacher MP, Margulies IM, Liotta LA: The activation of human type IV collagenase proenzyme. Sequence identification of the major conversion product following organomercurial activation. J Biol Chem 264: 1353-1356, 1989
Cawston TE, Barrett AJ: A rapid and reproducible assay for collagenase using [1-14C] acetylated collagen. Anal Biochem 99: 340-345, 1979
Brown PD, Kleiner DE, Unsworth EJ, Stetler-Stevenson WG: Cellular activation of the 72 kDa type IV procollagenase TIMP-2 complex. Kidney Int 43: 163-170, 1993
Laug WE: Secretion of plasminogen activators by cultured bovine endothelial cells: Partial purification, characterization and evidence for multiple forms. Thromb Haemost 45: 219-224, 1981
Laemmli UK: Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (London) 227: 680-685, 1970
Wray W, Boulikas T, Wray VP, Hancock R: Silver staining of proteins in polyacylamide gels. Anal Biochem 118: 197-203, 1981
Billings PC, Habres JM, Liao DC, Tuttle SW: Human fibroblasts contain a proteolytic activity which is inhibited by the Bowman-Birk protease inhibitor. Cancer Res 51: 5539-5543, 1991
Radi P, Beckam JS, Bush KM, Freeman BA: Peroxynitrite oxidation of sulfhhydryl. The cytotoxic potential of superoxide and nitric oxide. J Biol Chem 266: 4244-4250, 1991
Chakraborti S, Chakraborti T: Down regulation of protein kinase C attenuates the oxidant H2O2-mediated activation of phospholipase A2 in pulmonary smooth muscle cells. Cell Signalling 7: 75-83, 1995
Chakraborti T, Ghosh SK, Michael JR, Chakraborti S: Role of an aprotinin sensitive protease in the stimulation of Ca2+ ATPase by superoxide radical (O2·−) in microsomes of pulmonary smooth muscle. Biochem J 317: 885-890, 1996
Frears ER, Zhang Zhi, Blake DR, O'Connell JP, Winyard PG: Inactivation of tissue inhibitor of metalloproteinase-1 by peroxynitrite. FEBS Lett 381: 21-24, 1996
Matsudaira P. Sequence from picomole quantities of proteins electro-blotted onto polyvinylidene difluoride membranes. J Biol Chem 262: 10035-10038, 1987
David WW: In: Biostatistics: A Foundation for Analysis in Health Science. Wiley, New York, 1978, p 219
Stefansson S, Aimes RT, Seward NB, Alexander DS, Quigley JP: Native TIMP-free 70 kDa progelatinase (MMP-2) secreted at elevated levels by RSV transformed fibroblasts. J Cell Physiol 161: 419-428, 1994
Stetler-Stevenson W, Krutzsch HC, Liotta LA: TIMP-2: Identification and characterization of a new member of the metalloproteinase inhibitor family. Matrix 1(suppl): 299-306, 1992
Osthues A, Knauper V, Oberhoff R, Reinke H, Tschesche H: Isolation and characterization of tissue inhibitors of metalloproteinases (TIMP-1 and TIMP-2) from human rheumatoid synovial fluid. FEBS Lett 296: 16-20, 1992
Olson MW, Gervasi DC, Mobashery S, Fridman F: Kinetic analysis of the binding of human matrix metalloproteinase-2 and-9 to tissue inhibitor of metalloproteinase (TIMP)-1 and TIMP-2. J Bil Chem 272: 29975-29983, 1997
DeClerck YA, Yean TD, Lee Y, Tomich JM, Langley KE: Characterization of the functional domain of tissue inhibitor of metalloproteinases-2 (TIMP-2). Biochem J 289: 65-69, 1993
Ben-Yosef Y, Lahat N, Shapiro S, Bitterman H, Miller A: Regulation of endothelial matrix metalloproteinase-2 by hypoxia/reoxygenation. Circ Res 90: 784-791, 2002
Rauch BH, Bretschneider E, Braun M, Schror K: Factor Xa releases matrix metalloproteinase-2 (MMP-2) from human vascular smooth muscle cells and stimulates the conversion of pro-MMP-2 to MMP-2. Role of MMP-2 in factor Xa-induced DNA synthesis and matrix invasion. Circ Res 90: 1122-1127, 2002
Chou FP, Chu SC, Cheng MC, Yang SF, Cheung WN, Chiou HL, Hsieh YS: Effect of hemodialysis on the plasma level of type IV collagenases and their inhibitors. Clin Biochem 35: 383-388, 2002
Cho A, Reidy MA: Matrix metalloproteinase-9 is necessary for the regulation of smooth muscle cell replication and migration after arterial injury. Circ Res 91: 845-851, 2002
Thorgeirsson UP, Liotta LA, Kalebic T, Margulies IM, Thomas K, Rios-Candelore M, Russo RG: Effect of natural protease inhibitors and a chemoattractant on tumor cell invasion in vitro. J Natl Cancer Inst 69: 1049-1054, 1982
Mignatti P, Robbins E, Rifkin DB: Tumor invasion through the human amniotic membrane: Requirement for a proteinase cascade. Cell 47: 487-498, 1986
Okada Y, Morodomi T, Enghild JJ, Suzuki K, Yasui A, Nakanishi I, Salvesen G, Nagase H: Matrix metalloproteinase 2 from human rheumatoid synovial fibroblasts. Purification and activation of the precursor and enzymic properties. Eur J Biochem 194: 721-730, 1990
Fridman R, Bird RE, Hoyhtya M, Oelkuct M, Komarek D, Liang C-M, Berman ML, Liotta L, Stetler-Stevenson WG, Fuerst TR: Expression of human recombinant 72 kDa gelatinase and tissue inhibitor of metalloproteinase-2 (TIMP-2): Characterization of complex and free enzyme. Biochem J 289: 411-416, 1993
Beckman JS, Beckman TW, Chen J, Marshall PM, Freeman BA: Apparent hydroxyl radical production by peroxynitrite: Implications for endothelial injury from nitric oxide and superoxide. Proc Natl Acad Sci 87: 1620-1624, 1990
Zweier JL, Wang P, Samouilov A, Kuppuswamy P: Enzyme-independent formation of nitric oxide in biological tissues. Nature Med 1: 804-189, 1995
Huie RE, Padjama S: The reaction of NO with superoxide. Free Radic Res Commun 18: 195-199, 1993
Bond JS, Butler PE: Intracellular proteases. Annu Rev Biochem 56: 333-364, 1987
Matheson NR, Wong PS, Schuyler M, Travis J: Interaction of human α1-proteinase inhibitor with neutrophil meyloperoxidase. Biochemistry 20: 331-336, 1981
Burghuber OC, Strife RJ, Zirrolli J, Henson PM, Henson JE, Mathias MM, Reeves JT, Murphy RC, Voelkel NF: Leukotriene inhibitors attenuate rat lung injury induced by hydrogen peroxide. Am Rev Respir Dis 131: 778-785, 1985
Seeger W, Wolf H, Graubert E, Moser U, Neuhof H, Roka L: 1983 Influence of aprotinin and gabexate mesilate on arachidonic acid release by the Ca2+-ionophore A 23187 in the lung. Adv Exp Med Biol 156: 553-567, 1983
White RP: Pharmacodynamic effects of tosyl-arginine methylester (TAME) on isolated human arteries. J Gen Physiol 19: 387-392, 1988
Shabani F, McNeil J, Tippett L: The oxidative inactivation of tissue inhibitor of metalloproteinase-1 (TIMP-1) by hypochlorous acid (HOC1) is suppressed by anti-rheumatic drugs. Free Radic Res 28: 115-23, 1998
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Mandal, M., Mandal, A., Das, S. et al. Identification, purification and partial characterization of tissue inhibitor of matrix metalloproteinase-2 in bovine pulmonary artery smooth muscle. Mol Cell Biochem 254, 275–287 (2003). https://doi.org/10.1023/A:1027389602772
Issue Date:
DOI: https://doi.org/10.1023/A:1027389602772